Current Issues in the Pathogenesis, Diagnosis, and Treatment of Neonatal Thrombocytopenia

Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies

Volumn , Issue , 2008, Pages 11-32

  Saxonhouse, Matthew A ^a   Sola Visner, Martha C ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649936437     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603158-1.10002-2     Document Type: Chapter

References (189)

1. P Mehta, R Vasa, L Neumann, et al. (1980) Thrombocytopenia in the high-risk infant. J Pediatr 97 791-794
2. V Castle, M Andrew, J Kelton, et al. (1986) Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 108 749-755
3. P de Moerloose, F Boehlen, P Extermann, et al. (1998) Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay. Br J Haematol 100 735-740
4. S Chakravorty, N Murray and I Roberts (2005) Neonatal thrombocytopenia. Early Hum Dev 81 35-41.. Epub 2004 Nov 2019
5. S Sainio, AL Jarvenpaa, M Renlund, et al. (2000) Thrombocytopenia in term infants: a population-based study. Obstet Gynecol 95 441-446
6. NA Murray, LJ Howarth, MP McCloy, et al. (2002) Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 12 35-41
7. K Kaushansky, VC Broudy, N Lin, et al. (1995) Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92 3234-3238
8. K Kaushansky (1995) Thrombopoietin: the primary regulator of platelet production. Blood 86 419-431
9. MC Sola, DA Calhoun, AD Hutson, et al. (1999) Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 104 90-92
10. MC Sola, SE Juul, YG Meng, et al. (1999) Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. Early Hum Dev 53 239-250
11. NA Murray, TL Watts and IA Roberts (1998) Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 43 148-151
12. MC Sola, Y Du, AD Hutson, et al. (2000) Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 110 449-453
13. H Nishihira, Y Toyoda, H Miyazaki, et al. (1996) Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies. Br J Haematol 92 23-28
14. MC Sola, RD Christensen, AD Hutson, et al. (2000) Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys. Pediatr Res 47 208-214
15. MC Sola, Y CR, Du, AD Hutson, et al. (2002) Neonates fail to increase their marrow megakaryocyte mass in response to thrombocytopenia. Pediatr Res 51 242A
16. TA Olson, RF Levine, EM Mazur, et al. (1992) Megakaryocytes and megakaryocyte progenitors in human cord blood. Am J Pediatr Hematol Oncol 14 241-247
17. RF Levine, TA Olson, PK Shoff, et al. (1996) Mature micromegakaryocytes: an unusual developmental pattern in term infants. Br J Haematol 94 391-399
18. E Hegyi, M Nakazawa, N Debili, et al. (1991) Developmental changes in human megakaryocyte ploidy. Exp Hematol 19 87-94
19. PA de Alarcon and JL Graeve (1996) Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res 39 166-170
20. DC Ma, YH Sun, KZ Chang, et al. (1996) Developmental change of megakaryocyte maturation and DNA ploidy in human fetus. Eur J Haematol 57 121-127
21. G Mattia, F Vulcano, L Milazzo, et al. (2002) Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99 888-897
22. MC Sola, LM Rimsza and RD Christensen (1999) A bone marrow biopsy technique suitable for use in neonates. Br J Haematol 107 458-460
23. RV Emmons, DM Reid, RL Cohen, et al. (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87 4068-4071
24. G Zauli, L Valvassori and S Capitani (1993) Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. Blood 81 385-390
25. NA Murray and IA Roberts (1996) Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 40 112-119
26. MA Saxonhouse, RD Christensen, DM Walker, et al. (2004) The concentration of circulating megakaryocyte progenitors in preterm neonates is a function of post-conceptional age. Early Hum Dev 78 119-124
27. J Kienast and G Schmitz (1990) Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 75 116-121
28. MA Joseph, D Adams, J Maragos, et al. (1996) Flow cytometry of neonatal platelet RNA. J Pediatr Hematol Oncol 18 277-281
29. SM Peterec, SA Brennan, HM Rinder, et al. (1996) Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr 129 269-274
30. MA Saxonhouse, MC Sola, KM Pastos, et al. (2004) Reticulated platelet percentages in term and preterm neonates. J Pediatr Hematol Oncol 26 797-802
31. M Robinson, S Machin, I Mackie, et al. (2001) Comparison of glycocalicin, thrombopoietin and reticulated platelet measurement as markers of platelet turnover in HIV+ samples. Platelets 12 108-113
32. S van den Oudenrijn, M Bruin, CC Folman, et al. (2002) Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. Br J Haematol 117 390-398
33. F Fabris, I Cordiano, A Steffan, et al. (2000) Indirect study of thrombopoiesis (TPO, reticulated platelets, glycocalicin) in patients with hereditary macrothrombocytopenia. Eur J Haematol 64 151-156
34. A Kaser, G Brandacher, W Steurer, et al. (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98 2720-2725
35. C Dame, M Cremer, M Ballmaier, et al. (2001) Concentrations of thrombopoietin and interleukin-11 in the umbilical cord blood of patients with fetal alloimmune thrombocytopenia. Am J Perinatol 18 335-344
36. C Dame (2001) Thrombopoietin in thrombocytopenias of childhood. Semin Thromb Hemost 27 215-228
37. C Dame (2002) Developmental biology of thrombopoietin in the human fetus and neonate. Acta Paediatr Suppl 91 54-65
38. MC Sola, C Dame and RD Christensen (2001) Toward a rational use of recombinant thrombopoietin in the neonatal intensive care unit. J Pediatr Hematol Oncol 23 179-184
39. C Dame and AH Sutor (2005) Primary and secondary thrombocytosis in childhood. Br J Haematol 129 165-177
40. JL Bonan, HM Rinder and BR Smith (1993) Determination of the percentage of thiazole orange (TO)-positive, “reticulated” platelets using autologous erythrocyte TO fluorescence as an internal standard. Cytometry 14 690-694
41. KA Ault, HM Rinder, J Mitchell, et al. (1992) The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 98 637-646
42. GB Matic, ES Chapman, M Zaiss, et al. (1998) Whole blood analysis of reticulated platelets: improvements of detection and assay stability. Cytometry 34 229-234
43. EM Richards and TP Baglin (1995) Quantitation of reticulated platelets: methodology and clinical application. Br J Haematol 91 445-451
44. M Sola (2004) Evaluation and treatment of severe and prolonged thrombocytopenia in neonates. RD Christensen,(Eds) Hematopoietic growth factors in neonatal medicine, Vol. 31. Philadelphia: W.B. Saunders Company 1-14
45. Y Koike, A Yoneyama, J Shirai, et al. (1998) Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost 79 1106-1110
46. Y Kurata, S Hayashi, T Kiyoi, et al. (2001) Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol 115 656-664
47. MC Sola, RD Christensen, K Pastos, et al. (2004) Mechansims underlying severe and prolonged thrombocytopenia in neonates. Pediatr Res 55 291A
48. P Tighe, LM Rimsza, RD Christensen, et al. (2005) Severe thrombocytopenia in a neonate with congenital HIV infection. J Pediatr 146 408-413
49. SJ Israels, FS Odaibo, C Robertson, et al. (1997) Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res 41 218-223
50. DG Corby and I Schulman (1971) The effects of antenatal drug administration on aggregation of platelets of newborn infants. J Pediatr 79 307-313
51. DG Corby and TP O'Barr (1981) Neonatal platelet function: a membrane-related phenomenon? Haemostasis 10 177-185
52. KA Louden, F Broughton Pipkin, S Heptinstall, et al. (1994) Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. Br J Obstet Gynaecol 101 203-208
53. MM Mull and WE Hathaway (1970) Altered platelet function in newborns. Pediatr Res 4 229-237
54. CH Ts'ao, D Green and K Schultz (1976) Function and ultrastructure of platelets of neonates: enhanced ristocetin aggregation of neonatal platelets. Br J Haematol 32 225-233
55. SJ Israels, M Daniels and EM McMillan (1990) Deficient collagen-induced activation in the newborn platelet. Pediatr Res 27 337-343
56. DG Corby and TP O'Barr (1981) Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther 2 215-225
57. B Gelman, BN Setty, D Chen, et al. (1996) Impaired mobilization of intracellular calcium in neonatal platelets. Pediatr Res 39 692-696
58. SJ Israels, ML Rand and AD Michelson (2003) Neonatal platelet function. Semin Thromb Hemost 29 363-372
59. SJ Israels and M Andrew (1994) Haemostasis and thrombosis (3rd edn). Edinburgh (UK)
60. B Shenkman, N Linder, N Savion, et al. (1999) Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor. Pediatr Res 45 270-275
61. M Andrew, B Paes, R Milner, et al. (1987) Development of the human coagulation system in the full-term infant. Blood 70 165-172
62. M Andrew, B Paes, R Milner, et al. (1988) Development of the human coagulation system in the healthy premature infant. Blood 72 1651-1657
63. JA Katz, JL Moake, PD McPherson, et al. (1989) Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 73 1851-1858
64. MJ Weinstein, R Blanchard, JL Moake, et al. (1989) Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 72 68-72
65. SS Johnson, RR Montgomery and WE Hathaway (1981) Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation. Br J Haematol 47 597-606
66. C Watala, J Golanski, M Rozalski, et al. (2003) Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100? Thromb Res 109 299-306
67. L Gatti, D Guarneri, ML Caccamo, et al. (1996) Platelet activation in newborns detected by flow-cytometry. Biol Neonate 70 322-327
68. T Pietrucha, T Wojciechowski, J Greger, et al. (2001) Differentiated reactivity of whole blood neonatal platelets to various agonists. Platelets 12 99-107
69. T Kuhne and P Imbach (1998) Neonatal platelet physiology and pathophysiology. Eur J Pediatr 157 87-94
70. B Grosshaupt, W Muntean and P Sedlmayr (1997) Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr 156 944-948
71. D Rajasekhar, AS Kestin, FJ Bednarek, et al. (1994) Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 72 957-963
72. D Rajasekhar, MR Barnard, FJ Bednarek and AD Michelson (1997) Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 77 1002-1007
73. AG Sitaru, S Holzhauer, CP Speer, et al. (2005) Neonatal platelets from cord blood and peripheral blood. Platelets 16 203-210
74. N Hezard, G Potron, N Schlegel, et al. (2003) Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb Haemost 90 116-123
75. M Andrew, B Paes, J Bowker, et al. (1990) Evaluation of an automated bleeding time device in the newborn. Am J Hematol 35 275-277
76. F Fernandez, C Goudable, P Sie, et al. (1985) Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 59 139-148
77. PA Aarts, PA Bolhuis, KS Sakariassen, et al. (1983) Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood 62 214-217
78. M Andrew, B Paes and M Johnston (1990) Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 12 95-104
79. MC Sola, A del Vecchio, TJ Edwards, et al. (2001) The relationship between hematocrit and bleeding time in very low birth weight infants during the first week of life. J Perinatol 21 368-371
80. M Andrew, V Castle, S Saigal, et al. (1987) Clinical impact of neonatal thrombocytopenia. J Pediatr 110 457-464
81. LK Diamond and FS Porter (1958) The inadequacies of routine bleeding and clotting times. N Engl J Med 259 1025-1027
82. P Peterson, TE Hayes, CF Arkin, et al. (1998) The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 133 134-139
83. RP Rodgers and J Levin (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16 1-20
84. D Varon, R Dardik, B Shenkman, et al. (1997) A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 85 283-294
85. N Linder, B Shenkman, E Levin, et al. (2002) Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants. Arch Dis Child Fetal Neonatal Ed 86 F127-F130
86. Y Finkelstein, B Shenkman, L Sirota, et al. (2002) Whole blood platelet deposition on extracellular matrix under flow conditions in preterm neonatal sepsis. Eur J Pediatr 161 270-274. Epub 2002 Mar 2016
87. B Roschitz, K Sudi, M Kostenberger, et al. (2001) Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr 90 664-670
88. EF Mammen, RS Alshameeri and PC Comp (1995) Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost 21 113-121
89. SK Kundu, EJ Heilmann, R Sio, et al. (1995) Description of an in vitro platelet function analyzer -- PFA-100. Semin Thromb Hemost 21 106-112
90. M Boudewijns, M Raes, V Peeters, et al. (2003) Evaluation of platelet function on cord blood in 80 healthy term neonates using the Platelet Function Analyzer (PFA-100); shorter in vitro bleeding times in neonates than adults. Eur J Pediatr 162 212-213
91. MD Carcao, VS Blanchette, JA Dean, et al. (1998) The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 101 70-73
92. SJ Israels, T Cheang, EM McMillan-Ward, et al. (2001) Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 138 116-119
93. MS Saxonhouse, LR Rimsza, RD Christensen, et al. (2004) PFA-100 closure time in thrombocytopenic and non-thrombocytopenic neonates. Pediatr Res 55 289a
94. MA Saxonhouse, LR Rimsza, G Stevens, et al. (2005) Neonatal thrombocytopenia and PFA-100 closure times. Pediatr Res
95. GS Pahal, E Jauniaux, C Kinnon, AJ Thrasher, et al. (2000) Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation. Am J Obstet Gynecol 183 1029-1034
96. MC Sola, WB Slayton, LM Rimsza, et al. (2004) A neonate with severe thrombocytopenia and radio-ulnar synostosis. J Perinatol 24 528-530
97. PD Grossfeld, T Mattina, Z Lai, et al. (2004) The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A 129 51-61
98. JG Drachman (2004) Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 103 390-398.. Epub 2003 Sep 2022
99. U Pedersen-Bjergaard, M Andersen and PB Hansen (1998) Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs. Eur J Clin Pharmacol 54 701-706
100. JS Dlott, CF Danielson, DE Blue-Hnidy, et al. (2004) Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review. Ther Apher Dial 8 102-111
101. RH Aster (2005) Drug-induced immune cytopenias. Toxicology 209 149-153.. Epub 2005 Jan 2027
102. JV Aranda, A Portuguez-Malavasi, JM Collinge, et al. (1982) Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther 5 173-184
103. P Kumar, DA Hoppensteadt, MM Prechel, et al. (2004) Prevalance of heparin-dependent platelet-activating antibodies in preterm newborns after exposure to unfractionated heparin. Clin Appl Thromb Hemost 10 335-339
104. TN Nguyen, P Gal, JL Ransom, et al. (2003) Lepirudin use in a neonate with heparin-induced thrombocytopenia. Ann Pharmacother 37 229-233
105. M Schmugge, L Risch, AR Huber, et al. (2002) Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 109 E10
106. D Spadone, F Clark, E James, et al. (1992) Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 15 306-311. ; discussion 311–302
107. E Landmann, R Bluetters-Sawatzki, D Schindler, et al. (2004) Fanconi anemia in a neonate with pancytopenia. J Pediatr 145 125-127
108. A Butturini, RP Gale, PC Verlander, et al. (1994) Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 84 1650-1655
109. JB Bussel (2001) Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost 27 245-252
110. VS Blanchette and ML Rand (1997) Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol 21 53-62
111. MA Saxonhouse, LM Rimsza, G Stevens, et al. (2005) Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonates. Biol Neonate 89 104-108
112. MA Saxonhouse, LM Rimsza, RD Christensen, et al. (2003) Effects of anoxia on megakaryocyte progenitors derived from cord blood CD34pos cells. Eur J Haematol 71 359-365
113. LA Harker and CA Finch (1969) Thrombokinetics in man. J Clin Invest 48 963-974
114. JL Cole, UM Marzec, CJ Gunthel, et al. (1998) Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 91 3239-3246
115. DY Tate, GT Carlton, D Johnson, et al. (1981) Immune thrombocytopenia in severe neonatal infections. J Pediatr 98 449-453
116. M Andrew, P Vegh, C Caco, et al. (1993) A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 123 285-291
117. MG Garcia, E Duenas, MC Sola, et al. (2001) Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 21 415-420
118. A Del Vecchio, MC Sola, DW Theriaque, et al. (2001) Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions. Transfusion 41 803-808
119. BE Gibson, A Todd, I Roberts, et al. (2004) Transfusion guidelines for neonates and older children. Br J Haematol 124 433-453
120. RG Strauss, GJ Levy, C Sotelo-Avila, et al. (1993) National survey of neonatal transfusion practices: II. Blood component therapy. Pediatrics 91 530-536
121. R Strauss (2000) Blood banking and transfusion issues in perinatal medicine. R Christensen,(Eds) Hematologic problems of the neonate Philadelphia: W.B. Saunders
122. WJ Miller, J McCullough, HH Balfour Jr., et al. (1991) Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 7 227-234
123. DJ Lang, PA Ebert, BM Rodgers, et al. (1977) Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood. Transfusion 17 391-395
124. C Zwicky, JD Tissot, ZT Mazouni, et al. (1999) [Prevention of post-transfusion cytomegalovirus infection: recommendations for clinical practice]. Schweiz Med Wochenschr 129 1061-1066
125. MA Blajchman, M Goldman, JJ Freedman, et al. (2001) Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. Transfus Med Rev 15 1-20
126. L Eisenfeld, H Silver, J McLaughlin, et al. (1992) Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion 32 205-209
127. RG Strauss (1993) Selection of white cell-reduced blood components for transfusions during early infancy. Transfusion 33 352-357
128. GL Gilbert, K Hayes, IL Hudson, et al. (1989) Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1 1228-1231
129. MA Saxonhouse, W Slayton and MC Sola (2004) Platelet transfusions in the infant and child. CD Hillyer, RG Strauss, NLC Luban,(Eds) Handbook of pediatric transfusion medicine San Diego: Elsevier Academic Press 253-269
130. RG Strauss (2000) Data-driven blood banking practices for neonatal RBC transfusions. Transfusion 40 1528-1540
131. MR Sanders and JE Graeber (1990) Posttransfusion graft-versus-host disease in infancy. J Pediatr 117 159-163
132. H Ohto and KC Anderson (1996) Posttransfusion graft-versus-host disease in Japanese newborns. Transfusion 36 117-123
133. JB Bussel (1995) Fetal neonatal thrombocytopenia. Thromb Haemost 74 426-428
134. VS Blanchette (1988) Neonatal alloimmune thrombocytopenia: a clinical perspective. Curr Stud Hematol Blood Transfus 54 112-126
135. A Davoren, BR Curtis, RH Aster, et al. (2004) Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 44 1220-1225
136. JA Peterson, SM Balthazor, BR Curtis, et al. (2005) Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia. Transfusion 45 1487-1495
137. M Mandelbaum, D Koren, B Eichelberger, et al. (2005) Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Vox Sang 89 39-43
138. K Ertel, M Al-Tawil, S Santoso, et al. (2005) Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes. Transfusion 45 366-373
139. H Kroll, J Yates and S Santoso (2005) Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens. Transfusion 45 353-358
140. C Kaplan (2001) Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy. Transfus Clin Biol 8 311-314
141. PA de Alarcon (2005) Newborn platelet disorders. PA de Alarcon, E Werner,(Eds) Neonatal Hematology, Vol. 1 New York: Cambridge University Press 187-253
142. VS Blanchette, J Johnson and M Rand (2000) The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract Res Clin Haematol 13 365-390
143. GV Massey, NB McWilliams, DG Mueller, et al. (1987) Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia. J Pediatr 111 133-135
144. D Sidiropoulos and B Straume (1984) The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobin (IgG i.v.). Blut 48 383-386
145. DA Calhoun, RD Christensen, CS Edstrom, et al. (2000) Consistent approaches to procedures and practices in neonatal hematology. Clin Perinatol 27 733-753
146. R Kurzrock (2005) Thrombopoietic factors in chronic bone marrow failure states: the platelet problem revisited. Clin Cancer Res 11 1361-1367
147. R Kurzrock, M Talpaz, Z Estrov, et al. (1991) Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J Clin Oncol 9 1241-1250
148. DT Scadden, JD Levine, J Bresnahan, et al. (1995) In vivo effects of interleukin 3 in HIV type 1-infected patients with cytopenia. AIDS Res Hum Retroviruses 11 731-740
149. EC Guinan, YS Lee, KD Lopez, et al. (1993) Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia. Blood 81 1691-1698
150. SD Nimer, RL Paquette, P Ireland, et al. (1994) A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Exp Hematol 22 875-880
151. A Ganser, A Lindemann, G Seipelt, et al. (1990) Effects of recombinant human interleukin-3 in aplastic anemia. Blood 76 1287-1292
152. HH Wu, M Talpaz, RE Champlin, et al. (2003) Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses. Cancer 98 2410-2419
153. S Asano, A Okano, K Ozawa, et al. (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 75 1602-1605
154. E Bruno and R Hoffman (1989) Effect of interleukin 6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines. Exp Hematol 17 1038-1043
155. RJ Hill, MK Warren and J Levin (1990) Stimulation of thrombopoiesis in mice by human recombinant interleukin 6. J Clin Invest 85 1242-1247
156. T Ishibashi, H Kimura, T Uchida, et al. (1989) Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86 5953-5957
157. T Ishibashi, H Kimura, Y Shikama, et al. (1989) Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74 1241-1244
158. Z Pojda and A Tsuboi (1990) In vivo effects of human recombinant interleukin 6 on hemopoietic stem and progenitor cells and circulating blood cells in normal mice. Exp Hematol 18 1034-1037
159. CP Stahl, D Zucker-Franklin, BL Evatt, et al. (1991) Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates. Blood 78 1467-1475
160. MS Gordon, J Nemunaitis, R Hoffman, et al. (1995) A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood 85 3066-3076
161. C Isaacs, NJ Robert, FA Bailey, et al. (1997) Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. J Clin Oncol 15 3368-3377
162. JW Smith and 2nd (2000) Tolerability and side-effect profile of rhIL-11. Oncology (Williston Park) 14 41-47
163. JB Bussel, R Mukherjee and AJ Stone (2001) A pilot study of rhuIL-11 treatment of refractory ITP. Am J Hematol 66 172-177
164. EC Dickinson, R Tuncer, EP Nadler, et al. (2000) Recombinant human interleukin-11 prevents mucosal atrophy and bowel shortening in the defunctionalized intestine. J Pediatr Surg 35 1079-1083
165. EP Nadler, A Stanford, XR Zhang, et al. (2001) Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: interleukin-11 mRNA expression inversely correlates with extent of disease. J Pediatr Surg 36 1122-1129
166. M Chang, A Williams, L Ishizawa, et al. (1996) Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats. Blood Cells Mol Dis 22 57-67
167. Z Li, FJ Godinho, JH Klusmann, et al. (2005) Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet 37 613-619.. Epub 2005 May 2015
168. MC Erickson, E Delorme, L Giampa, et al. (2004) Biological activity and selectivity for Tpo receptor agonist, SB-497115. Blood 104 796a
169. VC Broudy and NL Lin (2004) AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 25 52-60
170. J Li, C Yang, Y Xia, et al. (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98 3241-3248
171. RL Basser, E O'Flaherty, M Green, et al. (2002) Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 99 2599-2602
172. JR Brown and GD Demetri (2002) Challenges in the development of platelet growth factors: low expectations for low counts. Curr Hematol Rep 1 110-118
173. JM Lusher, HR Roberts, G Davignon, et al. (1998) A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group. rFVIIa Study Group. Haemophilia 4 790-798
174. JM Lusher (1998) Early treatment with recombinant factor VIIa results in greater efficacy with less product. Eur J Haematol Suppl 63 7-10
175. J Kristensen, A Killander, E Hippe, et al. (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26 159-164
176. Y Laurian (2002) Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa? Pathophysiol Haemost Thromb 32 37-40
177. AM Almeida, K Khair, I Hann, et al. (2003) The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 121 477-481
178. A Chuansumrit, P Nuntnarumit, C Okascharoen, et al. (2002) The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. Pediatrics 110 169-171
179. A Chuansumrit, N Visanuyothin, S Puapunwattana, et al. (2002) Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency. J Med Assoc Thai 85(Suppl 4), S1059-S1064
180. WY Wong, WC Huang, R Miller, et al. (2000) Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia 6 50-54
181. N Olomu, R Kulkarni and M Manco-Johnson (2002) Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. J Perinatol 22 672-674
182. VA Hedberg and JM Lipton (1988) Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol 10 51-64
183. JG Hall, J Levin, JP Kuhn, et al. (1969) Thrombocytopenia with absent radius (TAR). Medicine (Baltimore) 48 411-439
184. WT Fayen and JW Harris (1980) Thrombocytopenia with absent radii (the TAR syndrome). Am J Med Sci 280 95-99
185. K Freson, K Devriendt, G Matthijs, et al. (2001) Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 98 85-92
186. GC Del Vecchio, L Giordani, A De Santis, et al. (2005) Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1. Acta Haematol 114 113-116
187. A Savoia, M Del Vecchio, A Totaro, et al. (1999) An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p. Am J Hum Genet 65 1401-1405
188. JG Drachman, GP Jarvik and MG Mehaffey (2000) Autosomal dominant thrombocytopenia: incomplete megakaryocyte differentiation and linkage to human chromosome 10. Blood 96 118-125
189. SD Roseff, NL Luban and CS Manno (2002) Guidelines for assessing appropriateness of pediatric transfusion. ransfusion 42 1398-1413